tradingkey.logo
tradingkey.logo
Search

Atossa Therapeutics Inc

ATOS
Add to Watchlist
2.070USD
-0.120-5.48%
Close 07-31 16:00ETQuotes delayed by 15 min
17.83MMarket Cap
LossP/E TTM

ATOS Financials

See Atossa Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Atossa Therapeutics Inc Earnings Date

Latest Release
May 8, 2026
EPS / Forecast
-1.11/-6.12
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-60.57
-1892.55%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-42.55%-1.11
-68.91%-1.27
-17.07%-1.01
-35.54%-0.98
-10.90%-0.78
-1114.98%-0.75
-1641.11%-0.86
-829.60%-0.72
-1318.35%-0.70
-4.61%-0.06
---0.05
---0.08
---0.05
---0.06
---0.15
----
----
----
----
----
Net Profit
-42.74%-9.59M
-72.32%-10.94M
-20.22%-8.69M
-39.25%-8.42M
-14.29%-6.72M
18.15%-6.35M
-16.07%-7.23M
38.46%-6.05M
6.42%-5.88M
-3.51%-7.75M
22.24%-6.23M
-47.33%-9.83M
-31.24%-6.28M
-55.04%-7.49M
-54.14%-8.01M
5.22%-6.67M
-35.27%-4.79M
59.69%-4.83M
-48.87%-5.20M
-80.21%-7.04M
Operating profit
-33.13%-9.87M
-59.92%-11.44M
-44.89%-9.25M
-27.23%-9.04M
-6.22%-7.41M
20.71%-7.15M
14.50%-6.38M
8.83%-7.11M
1.66%-6.98M
-10.83%-9.02M
8.98%-7.47M
-18.17%-7.79M
-49.53%-7.10M
-68.56%-8.14M
-59.05%-8.21M
5.84%-6.59M
-34.45%-4.75M
-14.25%-4.83M
-47.02%-5.16M
-77.95%-7.00M
Net Profit
-42.74%-9.59M
-72.32%-10.94M
-20.22%-8.69M
-39.25%-8.42M
-14.29%-6.72M
18.15%-6.35M
-16.07%-7.23M
38.46%-6.05M
6.42%-5.88M
-3.51%-7.75M
22.24%-6.23M
-47.33%-9.83M
-31.24%-6.28M
-55.04%-7.49M
-54.14%-8.01M
5.22%-6.67M
-35.27%-4.79M
59.69%-4.83M
-48.87%-5.20M
-80.21%-7.04M
Current assets
-46.66%36.67M
-38.73%45.62M
-27.79%55.68M
-23.50%62.52M
-21.03%68.74M
-19.26%74.46M
-21.03%77.11M
-22.91%81.72M
-21.48%87.06M
-21.98%92.22M
-20.87%97.65M
-20.55%106.00M
-18.98%110.87M
-16.31%118.20M
-13.70%123.39M
-8.51%133.42M
-2.97%136.85M
230.23%141.24M
1163.32%142.99M
1349.37%145.83M
Total current liabilities
37.46%7.46M
66.20%8.26M
41.91%8.22M
19.73%6.82M
1.82%5.42M
-5.14%4.97M
68.29%5.80M
63.77%5.70M
80.98%5.33M
-5.96%5.24M
20.08%3.44M
-8.28%3.48M
26.79%2.94M
78.12%5.57M
71.14%2.87M
111.12%3.79M
68.36%2.32M
-80.05%3.13M
7.06%1.68M
-1.67%1.80M
Total assets
-46.37%37.94M
-37.72%47.61M
-27.01%58.01M
-24.86%64.52M
-22.33%70.75M
-20.58%76.44M
-21.85%79.48M
-20.76%85.86M
-21.61%91.09M
-22.08%96.25M
-19.75%101.69M
-19.17%108.36M
-15.48%116.20M
-12.55%123.53M
-11.40%126.72M
-8.10%134.05M
-2.55%137.48M
229.75%141.26M
1150.46%143.02M
1329.28%145.87M
Total liabilities
37.46%7.46M
66.20%8.26M
41.91%8.22M
19.73%6.82M
1.82%5.42M
-5.14%4.97M
68.29%5.80M
63.77%5.70M
80.98%5.33M
-5.96%5.24M
20.08%3.44M
-8.28%3.48M
26.79%2.94M
78.12%5.57M
71.14%2.87M
111.12%3.79M
68.36%2.32M
-80.05%3.13M
6.97%1.68M
-1.93%1.80M
Total equity
-53.33%30.49M
-44.94%39.35M
-32.43%49.79M
-28.03%57.70M
-23.83%65.32M
-21.47%71.48M
-25.01%73.68M
-23.57%80.16M
-24.28%85.76M
-22.84%91.02M
-20.67%98.25M
-19.48%104.88M
-16.20%113.26M
-14.60%117.96M
-12.38%123.86M
-9.59%130.26M
-3.25%135.16M
408.45%138.14M
1331.94%141.35M
1620.40%144.07M
Net operating income
-60.78%-9.58M
-49.47%-10.54M
-26.42%-6.00M
-60.21%-7.26M
-26.84%-5.96M
-26.57%-7.05M
-22.33%-4.75M
-1.48%-4.53M
33.10%-4.70M
-23.17%-5.57M
28.23%-3.88M
24.95%-4.46M
-43.95%-7.02M
-23.40%-4.52M
-76.71%-5.41M
-11.48%-5.95M
-10.64%-4.88M
-6.78%-3.67M
-14.31%-3.06M
-139.36%-5.34M
Net investment
100.00%0.00
---7.00K
30.00%-7.00K
100.00%0.00
-50.00%-9.00K
--0.00
-900.00%-10.00K
76.92%-3.00K
---6.00K
100.00%0.00
99.96%-1.00K
---13.00K
100.00%0.00
-507170.71%-2.01M
-28699.49%-2.71M
--0.00
---13.00K
--396.00
-240.81%-9.40K
100.00%0.00
Net financing
--0.00
-100.00%0.00
--0.00
-100.00%0.00
-100.00%0.00
--3.37M
100.00%0.00
--100.00K
--204.00K
--0.00
---1.48M
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%718.00
-84.30%678.93K
2832.93%10.20M

FAQs

What are the current assets of Atossa Therapeutics Inc?

According to Atossa Therapeutics Inc's FY2025 earnings report, its current assets were 45.62M, with a year-on-year change of -38.73.

What are the total assets of Atossa Therapeutics Inc?

According to Atossa Therapeutics Inc's FY2025 earnings report, its total assets of Atossa Therapeutics Inc were 47.61M, with a year-on-year change of -37.72.

What are the total liabilities of Atossa Therapeutics Inc?

According to Atossa Therapeutics Inc's FY2025 earnings report, its total liabilities of Atossa Therapeutics Inc were 8.26M, with a year-on-year change of 66.20.

What is the total equity of Atossa Therapeutics Inc?

According to Atossa Therapeutics Inc's FY2025 earnings report, its total equity of Atossa Therapeutics Inc was 39.35M, with a year-on-year change of -44.94.

What is the net operating income of Atossa Therapeutics Inc?

According to Atossa Therapeutics Inc's FY2025 earnings report, its net operating income of Atossa Therapeutics Inc was -37.14M, with a year-on-year change of -34.47.

What is the net investment of Atossa Therapeutics Inc?

According to Atossa Therapeutics Inc's FY2025 earnings report, its net investment of Atossa Therapeutics Inc was -23.00K, with a year-on-year change of -21.05.

What is the Earnings Per Share (EPS) of Atossa Therapeutics Inc?

According to Atossa Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -60.57, with a year-on-year change of -1892.55.

What is the net income of Atossa Therapeutics Inc?

According to Atossa Therapeutics Inc's FY2025 earnings report, its net income was -34.77M, with a year-on-year change of -36.33.

What is the Return on Equity (ROE) of Atossa Therapeutics Inc?

According to Atossa Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -62.74, with a year-on-year change of -99.88.

What is the Return on Assets (ROA) of Atossa Therapeutics Inc?

According to Atossa Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -56.06, with a year-on-year change of -89.79.

What is the operating profit of Atossa Therapeutics Inc?

According to Atossa Therapeutics Inc's FY2025 earnings report, its operating profit was -37.14M, with a year-on-year change of -34.47.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.